Author

Emmelyne Dessein Corne

Institution: Debiopharm (Switzerland)

Observed institution: Debiopharm (Switzerland)

OpenAlex ID: A5117729344

Debio 0123, a highly selective WEE1 inhibitor in adult patients with advanced solid tumors: A phase 1 dose escalation and expansion monotherapy study.

2025 · Maria M. Rubinstein, Manish R. Sharma, et al. · Journal of Clinical Oncology · 2

Works count: 1

Citation count: 2

H-index: 1

I10-index: